This especially relates to the breast cancer subtypes which achieve the highest percentage of pCR (HER2-positive breast cancer and triple-negative breast cancer [TNBC]) (15) and simultaneously show the highest level of positive correlation between achieving pCR and favorable LTOs (16, 17). This evidence concerns the gene ERBB2 and breast carcinoma.